Safinamide

CHEMBL396778 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

302.3 g/mol

LogP

2.2

Phase

4

Taken as an add-on to levodopa therapy, this medication helps smooth out the motor fluctuations that Parkinson's patients experience as their levodopa dose wears off. It works by blocking the breakdown of dopamine and inhibiting certain nerve signals that become overactive in Parkinson's disease.

Peso molecular

302,3400 g/mol

LogP

2,20

TPSA

64,40 Å²

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Enfermedad de Parkinson

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O

InChI

InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1

Molecular Formula

C17H19FN2O2

HBD / HBA

2 / 4

Enlaces Rotables

7

Átomos Pesados

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Taken as an add-on to levodopa therapy, this medication helps smooth out the motor fluctuations that Parkinson's patients experience as their levodopa dose wears off. It works by blocking the breakdown of dopamine and inhibiting certain nerve signals that become overactive in Parkinson's disease.

Yes, Safinamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL396778. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 131682. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Safinamide en PillFYI

Estructura

Datos Rápidos

Fórmula: C17H19FN2O2
Sinónimos: 1

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.